Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson Johnson JNJ

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

StockNews.com

3 Healthcare Stocks for Long-Term Stability and Growth

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

StockNews.com

3 Dividend Stocks With 3% or More Yields to Watch Now

Dividend stocks are a top choice for long-term investors, with dependable payout and steady performance. Therefore, it could be wise to keep track of top dividend stocks, such as Johnson & Johnson (JNJ), Northwest Natural Holding Co. (NWN), and Universal Corp (UVV). Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stock Buys for Last-Minute Year-End Profits

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

StockNews.com

Catalyst Pharmaceuticals (CPRX) vs. Johnson & Johnson (JNJ): Predicting the Dominant Pharma Stock in 2024

Within the realm of burgeoning technological innovation and its seamless integration, the pharmaceutical industry emerges as a focal point for investors. Given this perspective, which of the two pharma stocks, Catalyst Pharmaceuticals (CPRX) and Johnson & Johnson (JNJ), holds greater potential for enduring returns in 2024? Read on….

StockNews.com

Analyzing 3 Pharma Stocks for Year-End Gains?

The pharma industry is well-positioned for expansion owing to growing healthcare spending and the adoption of cutting-edge technologies to develop new drugs. Amid this backdrop, let’s analyze the investment prospects of fundamentally strong pharma stocks Eli Lilly (LLY), Teva Pharmaceutical (TEVA), and Johnson & Johnson (JNJ) for year-end gains. Read…

StockNews.com

Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV

The pharmaceutical industry is set for long-term growth due to growing demand for quality drugs and therapies, an aging population, and the rise in lifestyle-related diseases. Now, let's explore the investment potential of industry giants Merck & Co (MRK), Johnson & Johnson (JNJ), and AbbVie (ABBV). Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb Company (BMY), could be wise investments to capitalize on right now. Read on….

StockNews.com

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

StockNews.com

Should You Invest in Johnson & Johnson (JNJ) Following Q3 Results

Johnson & Johnson’s (JNJ) third-quarter results impressed investors, as its earnings and revenue beat Wall Street estimates. Should investors consider investing in the stock following the solid third-quarter results? Read on to learn my view….

StockNews.com

Markets Today: Stocks Slip as Bond Yields Jump after U.S. Retail Sales Tops Forecasts

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.42%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.60%. Stock index futures this morning are moderately lower as the markets track diplomatic efforts to contain the Israel-Hamas conflict. Stock index futures extended their losses as...

Barchart

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

StockNews.com

Is Johnson & Johnson (JNJ) a Buy Before September Begins?

Pharma giant Johnson & Johnson (JNJ) has posted robust second-quarter results and raised its full-year outlook. Should investors look into the stock before September begins? Let’s look at its financial metrics to gauge its prospects….

StockNews.com

3 Large Cap ETFs Investors Are Watching Everyday

Amidst market turbulence, large-cap ETFs tend to deliver stability and reliable cash flows while demonstrating less volatility. Hence, fundamentally strong large-cap ETFs Vanguard Value (VTV), Vanguard High Dividend Yield (VYM) and iShares Russell 1000 Value (IWD) might be solid additions to one’s watchlist. Continue reading.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

Barchart

Markets Today: Stocks Fall on Disappointing Earnings from Netflix and Tesla

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.22%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.66%. Stock indexes this morning are lower as some disappointing quarterly earnings results weigh on technology stocks. Netflix is down more than -7% in pre-market trading...

StockNews.com

Investors Are Keeping This Healthcare Stock Long-Term

Despite an uncertain macro environment, healthcare giant Johnson & Johnson (JNJ) reported outstanding results in 2022, reflecting its business segments' continued strength. Moreover, the company has a history of increasing dividends for 60 consecutive years. Given its sustained business momentum and steady dividend payments, investors seem to stay committed to…

StockNews.com

3 Hot Stocks You Don't Want to Miss out on Right Now

The Silicon Valley Bank crisis will likely deter the Fed from raising interest rates by the expected 50 basis points next week. However, since the market is expected to remain highly volatile, it could be wise to invest in fundamentally strong stocks Johnson & Johnson (JNJ), Walmart (WMT), and General…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

1 Stock to Buy for Safety in This Volatile Market

With the Fed anticipating higher interest rate hikes than previously expected, the stock market is expected to remain volatile in the upcoming months. Given its strong balance sheet, brand recognition, and solid dividend payouts, it could be safe to invest in Johnson & Johnson (JNJ). Read more….

StockNews.com

3 Extremely Safe Stocks to Pick up in 2023

Recession possibilities persist as the Fed continues to fight the stubbornly high inflation. Given the uncertainties, investors could consider adding extremely safe stocks Johnson & Johnson (JNJ), The Descartes Systems (DSGX), and Weis Markets (WMK) to their portfolios this year. Keep reading.

StockNews.com

The 4 Best Forever Stocks to Buy in February 2023

The stock market volatility is not expected to end anytime soon as the macroeconomic headwinds remain. So, I think fundamentally solid Johnson & Johnson (JNJ), Gilead Sciences (GILD), Stellantis (STLA), and Cardinal Health (CAH) could be the best stocks to own now and forever. Keep reading.

StockNews.com

1 Dividend Stock to Buy for Passive Income in 2023

Healthcare giant Johnson & Johnson (JNJ) has a six-decade-long history of consecutive dividend growth. So, given the uncertainties surrounding the market, this fundamentally strong dividend-paying stock might be an ideal buy now. Read more.

StockNews.com

2 Stable Stocks to Add to Your Portfolio in 2023

Amid soaring concerns over an impending Fed-induced recession, the stock market could remain volatile in the near future. Against this backdrop, investors could add stable stocks Johnson & Johnson (JNJ) and Novartis (NVS) to their portfolios in 2023 to garner good returns. Read on….

StockNews.com

2 Stocks That Could Help You Sleep Peacefully No Matter What the Market Does

With strong job growth, unexpected inflation, and robust retail sales, the Fed’s tight monetary policy could stay in place for some time. Amid volatilities and anxiety soaring, fundamentally strong stocks Johnson & Johnson (JNJ) and Cisco Systems (CSCO) might be solid portfolio additions now. Read on….

People

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.